Onset of streptococcal toxic shock syndrome is accelerated by bruising in a mouse model

Microbial Pathogenesis

Volumn 44, Issue 4, 2008, Pages 339-343

  Seki, Masanori ^a   Saito, Mitsumasa ^a   Iida, Ken Ichiro ^a   Taniai, Hiroaki ^a   Soejima, Takashi ^a   Nakayama, Hiroaki ^a   Yoshida, Shin Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Bruise; Streptococcal toxic shock syndrome; Streptococcus pyogenes

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CONTROLLED STUDY; LEG AMPUTATION; LOG RANK TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BRUISING; STREPTOCOCCUS PYOGENES; SURVIVAL RATE; TOXIC SHOCK SYNDROME;

ANIMALS; BACTEREMIA; CONTUSIONS; DEATH, SUDDEN; DISEASE MODELS, ANIMAL; HUMANS; LEG; MALE; MICE; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; STREPTOCOCCUS PYOGENES;

EID: 40749083853     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.10.009     Document Type: Article

References (24)

1. Demers B., Simor A.E., Vellend H., et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 16 (1993) 792-800 discussion 801-2
2. Hoge C.W., Schwartz B., Talkington D.F., et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269 (1993) 384-389
3. Martin P.R., and Hoiby E.A. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 22 (1990) 421-429
4. Stevens D.L., Tanner M.H., Winship J., et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321 (1989) 1-7
5. Stevens D.L. Invasive group A streptococcus infections. Clin Infect Dis 14 (1992) 2-11
6. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269 (1993) 390-391
7. Ashbaugh C.D., Warren H.B., Carey V.J., and Wessels M.R. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 102 (1998) 550-560
8. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13 (2000) 470-511
9. Raeder R., and Boyle M.D. Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun 61 (1993) 1378-1384
10. Boyle M.D., Raeder R., Flosdorff A., and Podbielski A. Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection. J Infect Dis 177 (1998) 991-997
11. Okamoto S., Kawabata S., Nakagawa I., et al. Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J Virol 77 (2003) 4104-4112
12. Schmidt K.H., Podbielski A., Raeder R., and Boyle M.D. Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice. Microb Pathog 23 (1997) 347-355
13. Shiseki M., Miwa K., Nemoto Y., et al. Comparison of pathogenic factors expressed by group A streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever. Microb Pathog 27 (1999) 243-252
14. Sriskandan S., Unnikrishnan M., Krausz T., and Cohen J. Molecular analysis of the role of streptococcal pyrogenic Exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Mol Microbiol 33 (1999) 778-790
15. Saito M., Kajiwara H., Ishikawa T., et al. Delayed onset of systemic bacterial dissemination and subsequent death in mice injected intramuscularly with Streptococcus pyogenes strains. Microbiol Immunol 45 (2001) 777-786
16. Stamenkovic I., and Lew P.D. Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med 310 (1984) 1689-1693
17. Wood T.F., Potter M.A., and Jonasson O. Streptococcal toxic shock-like syndrome. The importance of surgical intervention. Ann Surg 217 (1993) 109-114
18. Iida K., Seki M., Saito M., et al. Capsule of Streptococcus pyogenes is essential for delayed death of mice in a model of streptococcal toxic shock syndrome. Microbiol Immunol 50 (2006) 127-130
19. Cowan M.R., Primm P.A., Scott S.M., et al. Serious group A beta-hemolytic streptococcal infections complicating varicella. Ann Emerg Med 23 (1994) 818-822
20. Doctor A., Harper M.B., and Fleisher G.R. Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics 96 (1995) 428-433
21. Bisno A.L., and Stevens D.L. Streptococcal infections of skin and soft tissues. N Engl J Med 334 (1996) 240-245
22. Gentry R.H., and Fitzpatrick J.E. A peculiar purple bruise. Necrotizing fasciitis due to a group-A beta-hemolytic streptococci. Arch Dermatol 126 (1990) 816-817 819-20
23. Hirose Y., Shibuya H., Okazaki E., et al. Toxic shock-like syndrome with flu-like prodrome: a possible role of 'enhancing tissue focus' for streptococcal toxic shock. J Infect 42 (2001) 195-200
24. Zittergruen M., and Grose C. Magnetic resonance imaging for early diagnosis of necrotizing fasciitis. Pediatr Emerg Care 9 (1993) 26-28